Regret and fear in prostate cancer: The relationship between treatment appraisals and fear of recurrence in prostate cancer survivors

ConclusionThese findings suggest that FOR may be mitigated by providing survivors with more information regarding treatment choices and the treatment itself so that men can make well‐informed decisions and experience less future regret.Sensitivity analysis for variables predicting FOR among prostate cancer survivors is not suspected of having a recurrence.
Source: Psycho-Oncology - Category: Cancer & Oncology Authors: Tags: PAPER Source Type: research

Related Links:

Publication date: 1 March 2019Source: Colloids and Surfaces B: Biointerfaces, Volume 175Author(s): Chang-Ming Liu, Guang-Bing Chen, Hui-Hong Chen, Jia-Bin Zhang, Hui-Zhang Li, Ming-Xiong Sheng, Wu-Bin Weng, Shan-Ming GuoAbstractNanoparticular drug delivery system (NDDS) has great potential for enhancing the efficacy of traditional chemotherapeutic drugs. However, it is still a great challenge to fabricate a biocompatible NDDS with simple structure capable of optimizing therapeutic efficacy, such as high tumor accumulation, suitable drug release profile (e.g. no premature drug leakage in normal physiological conditions whil...
Source: Colloids and Surfaces B: Biointerfaces - Category: Biochemistry Source Type: research
ConclusionsThere has been progress in the delivery of radiotherapy, enabling the administration of higher doses with minimal tradeoff in terms of slightly increased or equal toxicity. There is a need to focus future improvements in radiotherapy on sparing critical structures to reduce GU and GI morbidities. While complications such as fistulae, bone toxicity, and secondary malignancy are rare, there is a need for higher-quality studies assessing these outcomes and their management.Patient summaryIn this report, we review the literature regarding pelvic complications following modern primary prostate cancer radiotherapy and...
Source: European Urology - Category: Urology & Nephrology Source Type: research
Publication date: Available online 17 December 2018Source: European UrologyAuthor(s): Peter B. Østergren, Teemu J. Murtola, Mikkel Fode
Source: European Urology - Category: Urology & Nephrology Source Type: research
ConclusionsThe crosswalks are a valid way to convert between sexual and urinary domains of the MSK and EPIC-26 instruments.Patient summaryWe developed and validated a set of formulas that allow conversion of sexual and urinary function scores between the Memorial Sloan Kettering and Expanded Prostate Cancer Index Composite Short Form patient-reported outcome questionnaires. These crosswalks allow seamless transition between the two questionnaires.
Source: European Urology - Category: Urology & Nephrology Source Type: research
Publication date: Available online 17 December 2018Source: Saudi Pharmaceutical JournalAuthor(s): Nora A. AlkhudairAbstractProstate cancer is the second deadliest cancer in the US and the fourth most common cancer among Saudi males. Patients usually present with non-metastatic disease and treated with localized therapy. However, up to 40% of the patients will experience biochemical recurrence, within 10 years. Androgen deprivation therapy (ADT) is used in this setting to delay metastatic disease. Patients with high prostate-specific antigen (PSA), despite appropriate ADT, are diagnosed with castrate-resistant prostate canc...
Source: Saudi Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research
Ahmad Chaddad, Tamim Niazi, Stephan Probst, Franck Bladou, Maurice Anidjar, Boris Bahoric
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
(Dana-Farber Cancer Institute) Black men diagnosed with prostate cancer classified as low risk may actually have a more-aggressive form of the disease that is more likely to be fatal than in nonblack men placed in the same prognostic category, a new study suggests.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news
Authors: Wassersug RJ, Robinson J, Psych R, Walker L Abstract PMID: 30553278 [PubMed - in process]
Source: Canadian Journal of Urology - Category: Urology & Nephrology Tags: Can J Urol Source Type: research
AbstractMedical managements are becoming personalized while diseases are being understood at the molecular level. Nuclear medicine is one of the fields actively contributing to this development. In particular, theranostics, a combinatorial term for therapy and diagnostics, enables accurate imaging and subsequent targeted radionuclide treatment. Due to its high impact in healthcare, many countries have begun to offer Ga-68 PET/CT scans and Lu-177 therapies. The Philippines has followed suit through the initiative of this author and able support of the administration and staff of St. Luke ’s Medical Center. The Ga-68 D...
Source: Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Source Type: research
DiscussionCardiovascular irAEs are relatively rare (
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Prostate Cancer